NAVIN MOLECULAR
Live / Registered — Registered (as of 06 Sept 2022)
What this means for you
Registered since 06 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79308808
- Registration number
- 6835743
- Mark type
- Word mark
- Filed
- 21 Dec 2020
- Published for opposition
- 21 Jun 2022
- Registered
- 06 Sept 2022
- Attorney of record
- Alexander Lazouski
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin
Owner
Prosecution history
- 03 Jan 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Dec 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Dec 2022 — FINAL DISPOSITION PROCESSED
- 06 Dec 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jun 2022 — PUBLISHED FOR OPPOSITION
- 01 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 May 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Jan 2022 — NON-FINAL ACTION E-MAILED